Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 151
- Medical
Akanda Files For $27m IPO
Akanda Corp is set to become the latest cannabis-company to launch an Initial Public Offering (IPO), after it filed to launch on the NASDAQ stock exchange where it hopes to raise up to $27.6m
- Pharmaceutical
EU Cannabis Stocks Review: Love Hemp jumps 60%, OCT sees recovery & more from Cellular Goods, Chill Brands and MGC Pharma
On the 1-year anniversary of the first cannabis company to list on the London Stock Exchange, we examine the reaction to a number of significant announcements from some of the UK’s biggest cannabis players, making for an eventful week in the markets.
- CBD Market
Banking Blues For The Cannabis Industry
Banks, insurance companies and payment providers are refusing to work with cannabis-related companies throughout the UK, hampering the growth of the industry and leaving many in financial limbo.
- Medical
MGC Pharma Reports Strongest Ever Sales as Key Drug Approvals Remain in Limbo
MGC Pharmaceutical has reported its strongest ever quarterly sales figures, but a lack of significant progress on its drug trials and regulatory approvals saw a muted response from investors.
- CBD Market
Chill Brands Shares Fall Further 30% as it Scraps Retail ‘Rollout Timeline’
Chill Brands’ shares have fallen as much as 30% since Friday after it announced that it would be scrapping its ambitious retail ‘rollout timeline’.
- Adult-Use
Bloomwell’s $10m Cash Boost To Support Preparations For Germany’s Adult-Use Market
LEADING German medical cannabis healthcare company The Bloomwell Group, is preparing for a major push into the recreational market – and believes its peers would be ‘foolish’ not to.
- Uncategorized
Bloomwells 10-Millionen-Dollar-Bargeldzuschuss unterstützt die Vorbereitungen für den deutschen Markt für den Einsatz bei Erwachsenen
Das führende deutsche Gesundheitsunternehmen für medizinisches Cannabis, die Bloomwell Group, bereitet sich auf einen großen Vorstoß in den Freizeitmarkt vor – und glaubt, dass seine Konkurrenten “töricht” wären, es nicht zu tun.
- News
‘Thrifty’ Clever Leaves Looks To Bolster Its European Ambitions
CLEVER Leaves, a multinational global cannabis producer, has been granted a licence to more than double its cultivation facility in Portugal as it looks to Europe to help boost revenues after a difficult debut year as a listed company.
- News
Polish Cannabis Blockchain Start-Up Receives €400,000 Investment To Deliver Seed-To-Sale Supply Chain Security
TRUSTT has secured €400,000 in pre-seed funding to finance its ambitious blockchain tracing platform, which it believes will allow it to become a leading voice in the regulation of the European cannabis market.
- CBD Market
Industry Rocked As Leading UK Bank Shuts Its Doors To Cannabis Businesses
METRO Bank, one of the few institutions in the UK open to working with cannabis-related companies, is now closing its doors to the sector.
- Cultivation
Cannabis-Cautious Financial Regulators Delay UK Cultivator’s London Stock Exchange Plans
HELLENIC Dynamics, set to become the first ever cannabis cultivation company to list on the London Stock Exchange (LSE), is now planning to launch its IPO later this month.
- Pharmaceutical
Danish Biotech Firm Secures €2m Funding To Support Its Pharma-Focused Medical Cannabis Vision
TETRA Pharm has successfully completed its first external funding round raising €2m in capital to help it launch clinical trials and expand its operations across Europe.
